These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 17229495
41. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses. Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK. Vaccine; 2008 Jan 30; 26(5):614-22. PubMed ID: 18166249 [Abstract] [Full Text] [Related]
44. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood. Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Snawder JE, Robertson SA, Quinn CP. Clin Vaccine Immunol; 2006 May 30; 13(5):541-6. PubMed ID: 16682473 [Abstract] [Full Text] [Related]
51. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine. Klinman DM, Xie H, Ivins BE. Ann N Y Acad Sci; 2006 Oct 05; 1082():137-50. PubMed ID: 17145935 [Abstract] [Full Text] [Related]
57. A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials. Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP. Biologicals; 2010 Nov 28; 38(6):675-83. PubMed ID: 20875951 [Abstract] [Full Text] [Related]
58. Past, imminent and future human medical countermeasures for anthrax. Baillie LW. J Appl Microbiol; 2006 Sep 28; 101(3):594-606. PubMed ID: 16907809 [Abstract] [Full Text] [Related]
59. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Gu M, Hine PM, James Jackson W, Giri L, Nabors GS. Vaccine; 2007 Jan 05; 25(3):526-34. PubMed ID: 16973247 [Abstract] [Full Text] [Related]